DSRLF
Price
$107.68
Change
-$0.98 (-0.90%)
Updated
Jun 20 closing price
Capitalization
5.99B
FZMD
Price
$0.07
Change
+$0.01 (+16.67%)
Updated
Jun 5 closing price
Capitalization
5.99M
Interact to see
Advertisement

DSRLF vs FZMD

Header iconDSRLF vs FZMD Comparison
Open Charts DSRLF vs FZMDBanner chart's image
Diasorin S.R.L
Price$107.68
Change-$0.98 (-0.90%)
Volume$170
Capitalization5.99B
Fuse Medical
Price$0.07
Change+$0.01 (+16.67%)
Volume$5K
Capitalization5.99M
DSRLF vs FZMD Comparison Chart in %
Loading...
DSRLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FZMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DSRLF vs. FZMD commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DSRLF is a Hold and FZMD is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 05, 2025
Stock price -- (DSRLF: $107.68 vs. FZMD: $0.07)
Brand notoriety: DSRLF and FZMD are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: DSRLF: 68% vs. FZMD: 51%
Market capitalization -- DSRLF: $5.99B vs. FZMD: $5.99M
DSRLF [@Medical Specialties] is valued at $5.99B. FZMD’s [@Medical Specialties] market capitalization is $5.99M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DSRLF’s FA Score shows that 1 FA rating(s) are green whileFZMD’s FA Score has 0 green FA rating(s).

  • DSRLF’s FA Score: 1 green, 4 red.
  • FZMD’s FA Score: 0 green, 5 red.
According to our system of comparison, DSRLF is a better buy in the long-term than FZMD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DSRLF’s TA Score shows that 3 TA indicator(s) are bullish while FZMD’s TA Score has 4 bullish TA indicator(s).

  • DSRLF’s TA Score: 3 bullish, 4 bearish.
  • FZMD’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, FZMD is a better buy in the short-term than DSRLF.

Price Growth

DSRLF (@Medical Specialties) experienced а 0.00% price change this week, while FZMD (@Medical Specialties) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.95%. For the same industry, the average monthly price growth was +1.48%, and the average quarterly price growth was -0.02%.

Industries' Descriptions

@Medical Specialties (+1.95% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DSRLF($5.99B) has a higher market cap than FZMD($5.99M). DSRLF has higher P/E ratio than FZMD: DSRLF (27.32) vs FZMD (1.73). DSRLF YTD gains are higher at: 0.773 vs. FZMD (-6.573). DSRLF has higher annual earnings (EBITDA): 286M vs. FZMD (3.7M). DSRLF has more cash in the bank: 382M vs. FZMD (211K). FZMD has less debt than DSRLF: FZMD (2.08M) vs DSRLF (1.37B). DSRLF has higher revenues than FZMD: DSRLF (1.25B) vs FZMD (18.1M).
DSRLFFZMDDSRLF / FZMD
Capitalization5.99B5.99M99,917%
EBITDA286M3.7M7,726%
Gain YTD0.773-6.573-12%
P/E Ratio27.321.731,575%
Revenue1.25B18.1M6,917%
Total Cash382M211K181,043%
Total Debt1.37B2.08M65,993%
FUNDAMENTALS RATINGS
DSRLF vs FZMD: Fundamental Ratings
DSRLF
FZMD
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
14
Undervalued
49
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
62100
PRICE GROWTH RATING
1..100
5662
P/E GROWTH RATING
1..100
7587
SEASONALITY SCORE
1..100
1175

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DSRLF's Valuation (14) in the null industry is somewhat better than the same rating for FZMD (49). This means that DSRLF’s stock grew somewhat faster than FZMD’s over the last 12 months.

DSRLF's Profit vs Risk Rating (100) in the null industry is in the same range as FZMD (100). This means that DSRLF’s stock grew similarly to FZMD’s over the last 12 months.

DSRLF's SMR Rating (62) in the null industry is somewhat better than the same rating for FZMD (100). This means that DSRLF’s stock grew somewhat faster than FZMD’s over the last 12 months.

DSRLF's Price Growth Rating (56) in the null industry is in the same range as FZMD (62). This means that DSRLF’s stock grew similarly to FZMD’s over the last 12 months.

DSRLF's P/E Growth Rating (75) in the null industry is in the same range as FZMD (87). This means that DSRLF’s stock grew similarly to FZMD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DSRLFFZMD
RSI
ODDS (%)
Bearish Trend 3 days ago
37%
Bullish Trend 6 days ago
48%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
40%
Bullish Trend 3 days ago
65%
Momentum
ODDS (%)
Bearish Trend 3 days ago
30%
N/A
MACD
ODDS (%)
Bearish Trend 3 days ago
43%
N/A
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
34%
Bullish Trend 3 days ago
60%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
31%
Bullish Trend 3 days ago
54%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
Bearish Trend 3 days ago
67%
Aroon
ODDS (%)
Bearish Trend 3 days ago
48%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
DSRLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FZMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TOON0.780.02
+2.63%
Kartoon Studios
SPSC141.361.42
+1.01%
SPS Commerce
AAPL213.551.11
+0.52%
Apple
MGNI24.53-0.14
-0.57%
Magnite
NAAS0.80-0.01
-1.73%
NaaS Technology Inc

DSRLF and

Correlation & Price change

A.I.dvisor tells us that DSRLF and TWST have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DSRLF and TWST's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DSRLF
1D Price
Change %
DSRLF100%
N/A
TWST - DSRLF
28%
Poorly correlated
+1.30%
LMAT - DSRLF
26%
Poorly correlated
+0.84%
LUNG - DSRLF
21%
Poorly correlated
+2.21%
AVCRF - DSRLF
20%
Poorly correlated
N/A
CNVVY - DSRLF
16%
Poorly correlated
+3.46%
More

FZMD and

Correlation & Price change

A.I.dvisor tells us that FZMD and HOCPF have been poorly correlated (+11% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that FZMD and HOCPF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FZMD
1D Price
Change %
FZMD100%
N/A
HOCPF - FZMD
11%
Poorly correlated
+3.88%
ESLOY - FZMD
9%
Poorly correlated
-1.16%
DSRLF - FZMD
8%
Poorly correlated
N/A
ECIA - FZMD
8%
Poorly correlated
N/A
EKTAY - FZMD
6%
Poorly correlated
+0.39%
More